Results 191 to 200 of about 361,079 (214)

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine

Expert Review of Vaccines, 2018
Matthew Wasserman, Sarah J. Pugh, Raymond Farkouh   +2 more
exaly  

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

Vaccine, 2011
Elizabeth Miller, Mary P E Slack, Pauline A Waight   +2 more
exaly  

Pneumococcal conjugate vaccine

Inpharma Weekly, 1999
openaire   +1 more source

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Human Vaccines and Immunotherapeutics, 2019
Katrina M Nolan, Luwy Musey, Jeffrey B Rosen   +2 more
exaly  

Pneumococcal conjugate vaccination: correlates of protection

The Lancet Infectious Diseases, 2014
Angel, Vila-Corcoles, Olga, Ochoa-Gondar
openaire   +2 more sources

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution

Expert Review of Vaccines, 2018
Christopher Clarke, Patricia Izurieta, Bernard Hoet   +2 more
exaly  

Pneumococcal vaccine conjugate

Reactions Weekly, 2019
openaire   +1 more source

Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines

2018
Keith P. Klugman, Ron Dagan, Richard Malley, Cynthia G. Whitney   +3 more
openaire   +1 more source

The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014

Human Vaccines and Immunotherapeutics, 2016
Robert Cohen, Corinne Levy, Sandra Biscardi   +2 more
exaly  

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

2007
BIEMANS RALPH LEON, GARCON NATHALIE MARIE-JOSEPHE, HERMAND PHILIPPE VINCENT, POOLMAN JAN, VAN MECHELEN MARCELLE PAULETTE   +4 more
openaire   +5 more sources